Navigation Links
nContact's Cardiac Ablation Technology to be Presented in Two Noteworthy Posters at Boston Atrial Fibrillation Symposium 2012
Date:1/9/2012

MORRISVILLE, N.C., Jan. 9, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced its technology will be presented by physicians in two posters at the 17th Annual International Boston Atrial Fibrillation Symposium, January 12-14 in Boston, Massachusetts.  nContact will be showcasing its Numeris® Coagulation System with VisiTrax® and next generation EPi-Sense™ Coagulation System at its Boston AF Symposium booth #301.

nContact's epicardial ablation device integrates suction, perfusion and radiofrequency energy to ensure consistent cardiac tissue contact and create visible, continuous lesions on the epicardium of a beating heart. Access to the posterior of the atrium is achieved with unique access through the diaphragm with a SUBTLE (sub-thoracic, total endoscopic) approach for minimally invasive, closed-chest epicardial ablation.  

The technology will be presented in the following posters on Friday, January 13, 2012 available from 7:30 am until 6:30 pm:

  • Poster # 10 titled: "Prospective Reveal® XT Outcomes for the Convergent Atrial Fibrillation Ablation Procedure"
    Evaluates long-term outcomes of a multidisciplinary ablation procedure to treat persistent or longstanding persistent AF, as monitored by Reveal XT technology (Medtronic); presented by Borut Gersak, MD, of University Medical Center Ljubljana, Ljubljiana, Slovenia.
  • Poster #20 titled: "Multicenter Retrospective Outcomes for the Treatment of Atrial Fibrillation Using the Multidisciplinary Convergent Procedure"
    Examines outcomes of closed chest AF ablation procedure on patients with persistent or longstanding persistent AF across four U.S. sites; presented by Dr. Keith Golden of St. Vincent Hospital, Indianapolis, IN.
  • About nContact, Inc.
    nContact is a medical device company founded in 2005 with a mission to develop devices for the endoscopic treatment of arrhythmias, including atrial fibrillation (AF). The Numeris® Coagulation System with VisiTrax® is based on the unique integration of suction, perfusion, and RF energy to ensure the creation of visible, non-conductive, continuous, bi-atrial lesions on the epicardium of a beating heart.

    To date, the Numeris® Coagulation System with VisiTrax® is indicated for endoscopic coagulation of cardiac tissue in the United States. nContact has initiated IDE clinical studies for the treatment of AF in both open and closed chest procedures.

    The Numeris™ and EPi-Sense™ Coagulation Systems with VisiTrax® have CE Mark approval in Europe for the coagulation of cardiac tissue for the treatment of atrial fibrillation and atrial flutter. For more information, please visit www.ncontactinc.comMedia Contacts

     Beth Rose

    Kimberly MuscaranContact, Inc

    The Ruth Group T (919)655-1566 

    T (646) 536-7011brose@ncontactinc.com

    kmuscara@theruthgroup.com


    '/>"/>
    SOURCE nContact, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix
    2. FDA Approves Mechanical Cardiac Assist Device for Children With Heart Failure
    3. Australias Sporting Clubs Select Cardiac Science AEDs
    4. Roche, ChanTest Collaborate for Preclinical Cardiac Safety Testing of Drug Compounds Using iCell Cardiomyocytes and xCELLigence RTCA Cardio Instrument
    5. MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries
    6. Philips Launches HeartStart FR3 Automated External Defibrillator for Professional Responders Treating Victims of Sudden Cardiac Arrest
    7. MedSolutions Announces Program to Reduce Unnecessary Implantable Cardiac Defibrillator Surgeries
    8. Cardiac Dimensions Announces Presentation of Two-Year Efficacy Data From TITAN Clinical Trial
    9. Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
    10. "Today" Show, "Fox & Friends" Put Spotlight on Sudden Cardiac Arrest
    11. Cardiac Dimensions® Receives CE Mark Approval for Enhanced CARILLON® Mitral Contour System™
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/26/2016)... 26, 2016 One of Australia,s ... formation of a new biotechnology company, Noxopharm Limited [ABN 50 608 ... IPO and to list on the ASX. Noxopharm is ... to enter a Phase 1 clinical study later this year. ... one of the biggest problems facing cancer patients - the ability ...
    (Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
    (Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
    Breaking Medicine Technology:
    (Date:6/27/2016)... ... June 27, 2016 , ... ... only authorized OSHA Training Institute Education Center headquartered in Northern California, has issued ... from extreme heat at their worksites. Employers with workers exposed to high ...
    (Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
    (Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
    (Date:6/27/2016)... ... June 27, 2016 , ... ePAY ... partnership with Connance, a healthcare industry leader providing predictive analytics to optimize ... combine to provide health systems, hospitals and ambulatory surgical centers with dramatic ...
    (Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
    Breaking Medicine News(10 mins):